RT @beth_morton: Newer txs like the CGRPs mAbs have shown effectiveness in rebound. Given the MOTS trial results, it is effective to start…
3,045 followers
5,533 followers
Newer txs like the CGRPs mAbs have shown effectiveness in rebound. Given the MOTS trial results, it is effective to start a new preventive treatment like the CGRPs (or another) to treat rebound w/o stopping the “overused” acute med. https://t.co/pCIYddaTI7
5,533 followers
Ppl w/MOH: CGRP mAbs are as effective in CM patients w/MOH as in those w/out & can help ppl stop use of rebound-causing meds. The ⬇️ in MMDs & acute med days/month was seen regardless of if patients stop using the acute med or not. https://t.co/9fr
2,353 followers
Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors… https://t.co/5JtIrxn4a4 #hvhebron #neuro [Text complet] @BioMedCentral